A multidisciplinary expert panel from the American Society of Clinical Oncology has endorsed the updated European Association of Urology guidelines for the management of muscle-invasive bladder cancer, with one exception. The panel also provides additional clarification of several recommendations.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The prognostic value of routine preoperative blood parameters in muscle-invasive bladder cancer
BMC Urology Open Access 19 March 2020
-
Asymptomatic recurrence detection and cost-effectiveness in urothelial carcinoma
Medical Oncology Open Access 09 May 2018
-
A novel bladder cancer - specific oncolytic adenovirus by CD46 and its effect combined with cisplatin against cancer cells of CAR negative expression
Virology Journal Open Access 08 August 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Milowsky, M. I. et al. Guideline on muscle-invasive and metastatic bladder cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement. J. Clin. Oncol. 34, 1945–1952 (2016).
Nayan, M. et al. The initiation of a multidisciplinary bladder cancer clinic and the uptake of neoadjuvant chemotherapy: a time-series analysis. Can. Urol. Assoc. J. 10, 25–30 (2016).
International collaboration of trialists. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. Lancet 354, 533–540 (1999).
Grossman, H. B. et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N. Engl. J. Med. 349, 859–866 (2003).
Bochner, B. H. et al. Comparing open radical cystectomy and robot-assisted laparoscopic radical cystectomy: a randomized clinical trial. Eur. Urol. 67, 1042–1050 (2015).
Smith, N. D. et al. The RAZOR (randomized open versus robotic cystectomy) trial: study design and trial update. BJU Int. 115, 198–205 (2015).
Gray, P. J. et al. Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base. Eur. Urol. 63, 823–829 (2013).
Choi, W. et al. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell 25, 152–165 (2014).
Van Allen, E. M. et al. Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma. Cancer Discov. 4, 1140–1153 (2014).
Chou, R. et al. Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer (Agency for Healthcare Research and Quality (US), 2015).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
S.L. has worked with BioCancell, Vaxxion Therapeutics, UroGen Pharma, Telesta Therapeutics, Sitka Biopharma, Neucleixx, Taris Biomedical, Ferring Pharmaceuticals and the Bladder Cancer Journal. He has received grants from ENDO Intenational, FKD Therapies, Viventia Bio, Roche, Genentech and Genome DX.
Rights and permissions
About this article
Cite this article
Lerner, S. ASCO endorses EAU muscle-invasive bladder cancer guidelines. Nat Rev Urol 13, 440–441 (2016). https://doi.org/10.1038/nrurol.2016.114
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2016.114
This article is cited by
-
The prognostic value of routine preoperative blood parameters in muscle-invasive bladder cancer
BMC Urology (2020)
-
Asymptomatic recurrence detection and cost-effectiveness in urothelial carcinoma
Medical Oncology (2018)
-
A novel bladder cancer - specific oncolytic adenovirus by CD46 and its effect combined with cisplatin against cancer cells of CAR negative expression
Virology Journal (2017)
-
Bladder cancer
Nature Reviews Disease Primers (2017)